ADVFN ADVFN

Hot Features

Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc (SNOA)

1,20
-0,01
(-0,83%)
Fermé 05 Juillet 10:00PM
1,2001
0,0001
(0,01%)
Après les heures de négociation: 11:40PM

Sonoma Pharmaceuticals Inc (SNOA) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,2001
( -0,82% )
Prix Achat
1,16
Prix Vente
1,23
Volume échangé
60 654
1,19 Fourchette du Jour 1,225
0,8501 Plage de 52 semaines 6,9199
Cap du marché
Clôture Veille
1,21
Ouverture
1,22
Dernière Transaction
30
@
1.2264
Dernière heure de transaction
Volume financier
US$ 73 453
VWAP
1,211
Volume moyen (3 m)
US$ 237 767
Actions en circulation
4 785 801
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-0,64
Bénéfice par action (BPA)
-1,89
Chiffre d'affairess (LTM)
19,53M
Bénéfice net (LTM)
-3,18M

À propos de Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin t... Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Boulder, United States
Fondé
1999
Sonoma Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker SNOA. Le dernier cours de clôture d'Sonoma Pharmaceuticals était de US$1,21. Au cours de la dernière année, les actions de Sonoma Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,8501 à US$ 6,9199.

Sonoma Pharmaceuticals compte actuellement 4 785 801 actions en circulation. La capitalisation boursière d'Sonoma Pharmaceuticals est de US$5,74 million. Sonoma Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.64.

SNOA Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.05014.356521739131.151.271.12354081.21961556CS
40.00010.008333333333331.21.271.031722581.15155126CS
12-1.0799-47.36403508772.282.880.85012508931.25763224CS
26-2.3399-66.09887005653.543.8920.85011288161.38588804CS
52-1.7499-59.31864406782.956.91990.85013955854.45618537CS
1560.140113.21698113211.066.91990.115911224251.45435889CS
260-6.2099-83.80431848857.4113.360.115910746592.60026439CS

SNOA - Frequently Asked Questions (FAQ)

What is the current Sonoma Pharmaceuticals Inc share price?
The current share price of Sonoma Pharmaceuticals Inc is US$ 1,2001
How many Sonoma Pharmaceuticals Inc shares are in issue?
Sonoma Pharmaceuticals Inc has 4 785 801 shares in issue
What is the market cap of Sonoma Pharmaceuticals Inc?
The market capitalisation of Sonoma Pharmaceuticals Inc is USD 5,74M
What is the 1 year trading range for Sonoma Pharmaceuticals Inc share price?
Sonoma Pharmaceuticals Inc has traded in the range of US$ 0,8501 to US$ 6,9199 during the past year
What is the PE ratio of Sonoma Pharmaceuticals Inc?
The price to earnings ratio of Sonoma Pharmaceuticals Inc is -0,64
What is the cash to sales ratio of Sonoma Pharmaceuticals Inc?
The cash to sales ratio of Sonoma Pharmaceuticals Inc is 0,3
What is the registered address of Sonoma Pharmaceuticals Inc?
The registered address for Sonoma Pharmaceuticals Inc is 5445 Conestoga Court, Boulder, Colorado, 80301
What is the Sonoma Pharmaceuticals Inc website address?
The website address for Sonoma Pharmaceuticals Inc is sonomapharma.com
Which industry sector does Sonoma Pharmaceuticals Inc operate in?
Sonoma Pharmaceuticals Inc operates in the Pharmaceuticals sector

SNOA Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock